Taylor Billion, Logan Verheyen, Ali Bin Abdul Jabbar, Noureen Asghar, Mohsin Mirza, Muazzam Mirza, Abubakar Tauseef
{"title":"Regional trends and disparities of lung cancer mortality in the United States, 1999-2022: a retrospective cohort study.","authors":"Taylor Billion, Logan Verheyen, Ali Bin Abdul Jabbar, Noureen Asghar, Mohsin Mirza, Muazzam Mirza, Abubakar Tauseef","doi":"10.1186/s12931-025-03344-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Lung cancer is the leading cause of cancer death in the US and worldwide. This study examines regional and state-level trends in lung cancer mortality in the US from 1999 to 2022.</p><p><strong>Methods: </strong>Center for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) was used to obtain data on lung cancer mortality in people ages 25 years and older. Age-Adjusted Mortality Rate (AAMR) was calculated along with Annual Percent Change (APC) and Average Annual Percent Change (AAPC).</p><p><strong>Results: </strong>In general, the age-adjusted mortality rate (AAMR) for lung cancer declined from 91.4 (95% CI 91.0 to 91.9) in 1999 to 52.0 (95% CI 51.7 to 52.2) in 2022. Throughout the study, the Midwest and South regions consistently exhibited the highest mortality rates. Notably, distinct patterns emerged when analyzing mortality rates by race and gender within each region.</p><p><strong>Conclusion: </strong>This study revealed significant variations in lung cancer mortality at both regional and state levels. Recognizing these disparities is essential for healthcare policymakers and researchers to monitor progress in reducing lung cancer deaths and identifying the populations most vulnerable to this disease.</p>","PeriodicalId":49131,"journal":{"name":"Respiratory Research","volume":"26 1","pages":"280"},"PeriodicalIF":5.8000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12931-025-03344-0","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Lung cancer is the leading cause of cancer death in the US and worldwide. This study examines regional and state-level trends in lung cancer mortality in the US from 1999 to 2022.
Methods: Center for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research (CDC WONDER) was used to obtain data on lung cancer mortality in people ages 25 years and older. Age-Adjusted Mortality Rate (AAMR) was calculated along with Annual Percent Change (APC) and Average Annual Percent Change (AAPC).
Results: In general, the age-adjusted mortality rate (AAMR) for lung cancer declined from 91.4 (95% CI 91.0 to 91.9) in 1999 to 52.0 (95% CI 51.7 to 52.2) in 2022. Throughout the study, the Midwest and South regions consistently exhibited the highest mortality rates. Notably, distinct patterns emerged when analyzing mortality rates by race and gender within each region.
Conclusion: This study revealed significant variations in lung cancer mortality at both regional and state levels. Recognizing these disparities is essential for healthcare policymakers and researchers to monitor progress in reducing lung cancer deaths and identifying the populations most vulnerable to this disease.
期刊介绍:
Respiratory Research publishes high-quality clinical and basic research, review and commentary articles on all aspects of respiratory medicine and related diseases.
As the leading fully open access journal in the field, Respiratory Research provides an essential resource for pulmonologists, allergists, immunologists and other physicians, researchers, healthcare workers and medical students with worldwide dissemination of articles resulting in high visibility and generating international discussion.
Topics of specific interest include asthma, chronic obstructive pulmonary disease, cystic fibrosis, genetics, infectious diseases, interstitial lung diseases, lung development, lung tumors, occupational and environmental factors, pulmonary circulation, pulmonary pharmacology and therapeutics, respiratory immunology, respiratory physiology, and sleep-related respiratory problems.